BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1493967)

  • 1. [Immunohistochemical findings in otosclerotic lesions].
    Altermatt HJ; Gerber HA; Gaeng D; Müller C; Arnold W
    HNO; 1992 Dec; 40(12):476-9. PubMed ID: 1493967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Otosclerosis. A paramyxovirus-induced inflammatory reaction].
    Arnold W; Altermatt HJ; Kraft R; Pfaltz CR
    HNO; 1989 Jun; 37(6):236-41. PubMed ID: 2787314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis of otosclerosis. "State of the art"].
    Arnold W; Niedermeyer HP; Altermatt HJ; Neubert WJ
    HNO; 1996 Mar; 44(3):121-9. PubMed ID: 8641897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry of otosclerosis.
    Arnold W; Friedmann I
    Acta Otolaryngol Suppl; 1990; 470():124-8; discussion 128-9. PubMed ID: 2239226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of collagens in the otosclerotic bone.
    Niedermeyer HP; Becker ET; Arnold W
    Adv Otorhinolaryngol; 2007; 65():45-49. PubMed ID: 17245021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of measles and rubella-specific antigens in the endochondral ossification zone in otosclerosis].
    Arnold W; Friedmann I
    Laryngol Rhinol Otol (Stuttg); 1987 Apr; 66(4):167-71. PubMed ID: 2439859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The manifestation and significance of vimentin-9 in the otosclerotic stapes].
    Wang PV
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(1):6-7, 58. PubMed ID: 8352998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of major histocompatibility antigens in human chronic pancreatitis.
    Jalleh RP; Gilbertson JA; Williamson RC; Slater SD; Foster CS
    Gut; 1993 Oct; 34(10):1452-7. PubMed ID: 8244120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex (MHC)-I and MHC-II expression in Hodgkin's disease in relation to the presence of Epstein-Barr Virus (EBV).
    Tzardi M; Kouvidou C; Papakonstantinou E; Datseris G; Darivianaki K; Karidi E; Eliopoulos G; Delidis G; Rontogianni D; Kanavaros P
    Anticancer Res; 1996; 16(2):827-31. PubMed ID: 8687136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.
    Medeiros LJ; Gelb AB; Wolfson K; Doggett R; McGregor B; Cox RS; Horning SJ; Warnke RA
    Am J Pathol; 1993 Oct; 143(4):1086-97. PubMed ID: 8214004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis.
    Gruschwitz M; Sepp N; Kofler H; Wick G
    Immunobiology; 1991 Jun; 182(3-4):234-55. PubMed ID: 1833311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical studies in equine recurrent uveitis (ERU).
    Romeike A; Brügmann M; Drommer W
    Vet Pathol; 1998 Nov; 35(6):515-26. PubMed ID: 9823593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated osteoclasts with CD51/61 expression in otosclerosis.
    Karosi T; Jókay I; Kónya J; Petkó M; Szabó LZ; Pytel J; Jóri J; Sziklai I
    Laryngoscope; 2006 Aug; 116(8):1478-84. PubMed ID: 16885757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-associated novel CD46 splicing variants and pathologic bone remodeling in otosclerosis.
    Karosi T; Szalmás A; Csomor P; Kónya J; Petkó M; Sziklai I
    Laryngoscope; 2008 Sep; 118(9):1669-76. PubMed ID: 18677279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
    Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M
    J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
    Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
    Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic and immunohistochemical observation of otosclerotic stapes: a preliminary study.
    Lim DJ; Robinson M; Saunders WH
    Am J Otolaryngol; 1987; 8(5):282-95. PubMed ID: 2829642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC antigen expression in human oral squamous carcinoma cell lines.
    Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
    J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminal bacterial antigen-specific CD4+ T-cell responses in HLA-B27 transgenic rats with chronic colitis are mediated by both major histocompatibility class II and HLA-B27 molecules.
    Qian BF; Tonkonogy SL; Balfour Sartor R
    Immunology; 2006 Mar; 117(3):319-28. PubMed ID: 16476051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.